Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk

被引:28
作者
Combarros, O. [1 ,2 ]
Sanchez-Juan, P. [3 ]
Riancho, J. A. [4 ]
Mateo, I. [1 ,2 ]
Rodriguez-Rodriguez, E. [1 ,2 ]
Infante, J. [1 ,2 ]
Garcia-Gorostiaga, I. [1 ,2 ]
Vazquez-Higuera, J. L. [1 ,2 ]
Berciano, J. [1 ,2 ]
机构
[1] Univ Cantabria, Marques Valdecilla Univ Hosp, Neurol Serv, Santander 39008, Spain
[2] Univ Cantabria, Marques Valdecilla Univ Hosp, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Santander 39008, Spain
[3] Fdn Marques de Valdecilla IFIMAV, Inst Format & Res, Santander, Spain
[4] Univ Cantabria, Marques Valdecilla Univ Hosp, Dept Internal Med, E-39005 Santander, Spain
关键词
Alzheimer's disease; aromatase; interleukin-10; polymorphism; epistasis;
D O I
10.1007/s00702-008-0028-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A chronic inflammatory process with activation of microglial cells contribute to the neurodegeneration associated with Alzheimer's disease (AD). Estrogen could protect the brain from neurodegeneration by augmenting the secretion of the anti-inflammatory interleukin (IL)-10 from microglial cells. In a case-control study in 231 AD patients and 194 healthy controls, we examined whether the combined effects between the genes coding for aromatase (a critical enzyme in the peripheral synthesis of estrogens) and IL-10 might be responsible for susceptibility to AD. Subjects carrying both the aromatase (5'-UTR) GG and the IL-10 (-1082) GG genotypes had a six times lower risk of developing AD than subjects without these risk genotypes (OR = 0.17, 95% CI = 0.04-0.77, P = 0.02).
引用
收藏
页码:863 / 867
页数:5
相关论文
共 17 条
[1]
Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease [J].
Arosio, B ;
Trabattoni, D ;
Galimberti, L ;
Bucciarelli, P ;
Fasano, F ;
Calabresi, C ;
Cazzullo, CL ;
Vergani, C ;
Annoni, G ;
Clerici, M .
NEUROBIOLOGY OF AGING, 2004, 25 (08) :1009-1015
[2]
Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk [J].
Combarros, O ;
Riancho, JA ;
Infante, J ;
Sañudo, C ;
Llorca, J ;
Zarrabeitia, MT ;
Berciano, J .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 20 (2-3) :153-157
[3]
Estrogen and brain inflammation: Effects on microglial expression of MHC, costimulatory molecules and cytokines [J].
Dimayuga, FO ;
Reed, JL ;
Carnero, GA ;
Wang, CM ;
Dimayuga, ER ;
Dimayuga, VM ;
Perger, A ;
Wilson, ME ;
Keller, JN ;
Bruce-Keller, AJ .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 161 (1-2) :123-136
[4]
Estrogen-containing hormon therapy and Alzheimer's disease risk: Understanding discrepant inferences from observational and experimental research [J].
Henderson, VW .
NEUROSCIENCE, 2006, 138 (03) :1031-1039
[5]
CYP19 haplotypes increase risk for Alzheimer's disease [J].
Huang, R. ;
Poduslo, S. E. .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (08)
[6]
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease [J].
Iivonen, S ;
Corder, E ;
Lehtovirta, M ;
Helisalmi, S ;
Mannermaa, A ;
Vepsäläinen, S ;
Hänninen, T ;
Soininen, H ;
Hiltunen, M .
NEUROLOGY, 2004, 62 (07) :1170-1176
[7]
Estrogen receptor a and its splice variants in the hippocampus in aging and Alzheimer's disease [J].
Ishunina, Tatjana A. ;
Fischer, David F. ;
Swaab, Dick F. .
NEUROBIOLOGY OF AGING, 2007, 28 (11) :1670-1681
[8]
Interfleukin-10 promoter polymorphism in sporadic Alzheimer's disease [J].
Lio, D ;
Licastro, F ;
Scola, L ;
Chiappelli, M ;
Grimaldi, LM ;
Crivello, A ;
Colonna-Romano, G ;
Candore, G ;
Franceschi, C ;
Caruso, C .
GENES AND IMMUNITY, 2003, 4 (03) :234-238
[9]
Inflammation, genetics, and longevity:: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-α-308 promoter SNP [J].
Lio, D ;
Scola, L ;
Crivello, A ;
Colonna-Romano, G ;
Candore, G ;
Bonafè, M ;
Cavallone, L ;
Marchegiani, F ;
Olivieri, F ;
Franceschi, C ;
Caruso, C .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (04) :296-299
[10]
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939